Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1637 1638 1755 1758 1775 1793 1796 1799
This examiner grants 20% of resolved cases
Michael A. Marcheschi has resolved 100 cases in Art Unit 1637 within Tech Center 1700. His allowance rate is 20.0%, which suggests a rigorous examination process for applications in this biotechnology and chemical sector. Practitioners should prepare for a potentially long prosecution timeline, as the median days to allowance for this examiner is 1321. This 1321-day pendency is a critical factor for applicants to consider when planning their strategy.
The data indicates that interviews are a useful tool for overcoming rejections with Marcheschi. He shows an interview lift of 17.9%, which represents the increase in the likelihood of allowance when an interview is conducted. Given the 20.0% baseline allowance rate and 100 resolved cases, engaging in direct dialogue may be a critical strategy for advancing applications toward a successful resolution. Practitioners should use this 17.9% lift to improve their 20.0% chance of success in Art Unit 1637.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17799606 | CELL CULTURE VESSEL | Non-Final OA | LG ELECTRONICS INC. |
| 18328967 | Portable Closed System for Culturing Cells Using Small Volumes of Capillary Blood | Non-Final OA | Northwestern University |
| 18558892 | Methods and Systems for Single-Step Decontamination and Enzymatic Degradation of Bio-Based Polymers | Non-Final OA | Kimberly-Clark Worldwide, Inc. |
| 18229636 | BIOLOGICAL SPECIMEN INCUBATOR | Non-Final OA | Analog Devices, Inc. |
| 17998011 | METHODS FOR ORGANOIDS PRODUCTION | Non-Final OA | CITY OF HOPE |
| 18508563 | Addressable Microfluidics Systems and Methods for In Vivo Applications | Final Rejection | New Jersey Institute of Technology |
| 18114060 | GROWTH SYSTEM AND METHOD FOR FUNGAL BIOMASS | Non-Final OA | Mushlabs GmBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy